In his 2017 budget that will be sent to Congress next week, President Obama is requesting another $755 million for Vice President Biden’s “moonshot” cancer initiative, White House officials said today. Congress has already allocated nearly $200 million to the program in last year’s budget, which will bring the total spending to almost $1 billion if they fulfill Obama’s proposal. Here’s an overview of how that money would be used.
The money would be allocated into six main research areas:
- Immunotherapy
- Technology to detect cancer earlier
- Vaccines for cancer-causing viruses
- More data sharing and scientific collaboration
- Genomic analyses
- Pediatric cancer
It would go to these institutions:
- The National Institutes of Health would receive the biggest chunk of funds
- The Food and Drug Administration would get $75 million, mostly for work with data, as Stat News reports
- The Department of Defense and the Department of Veterans Affairs would increase their number of long-term studies into risk factors for cancer
- Vice President’s Exceptional Opportunities in Cancer Research Fund, a new funding body that would back “high-risk, high-return research, as Reuters reports, as well as collaborations between businesses and non-profits
This announcement comes just a few weeks after the president announced the cancer moonshot initiative at the State of the Union address. He chose Biden to lead the charge; today, Biden is meeting with the members of the federal task force outlining that initiative, according to a blog post.
With this increased funding, officials hope to achieve a decade’s worth of scientific breakthroughs in half that time. But they’ve yet to outline, concretely, how the program defines success; though officials say the specific goals will be announced soon, critics have pointed to this fuzzy endpoint as one of the biggest weaknesses of the cancer moonshot effort.
The rest of the 2017 budget will be released on February 9.
